Rapid Therapeutic Science Laboratories, Inc. (OTCPK: RTSL)
Health Care · Health Care Equipment & Supplies · US
$0.00
— today · -87.9% 1Y
Rapid Therapeutic Science Laboratories, Inc. (OTCPK: RTSL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $7.59K and employs 3 people.
Over the last twelve months the share price has lost 87.9%, trading between 0.00 and 0.01.
Tweenvest scores Rapid Therapeutic Science Laboratories, Inc. across four factors: quality 16/100. Its strongest factor is quality.
RTSL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.59K
- Revenue (TTM)
- —
- P/E
- 0.05
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- -13.73
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.99M
- Employees
- 3
- Next earnings
- —
About Rapid Therapeutic Science Laboratories, Inc.
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.
- ISIN
- US7534312043
- Founded
- 2013
- Listed since
- Jun 14, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.